BackCatabasis Pharmaceuticals Overview

Catabasis Pharmaceuticals Common Stock

Latest common stock for CATB: $57K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$57000.00

Peer average / median

Loading

Catabasis Pharmaceuticals Common Stock History

Loading

Catabasis Pharmaceuticals vs. peers: Common Stock Comparison

Loading

Catabasis Pharmaceuticals Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Catabasis Pharmaceuticals (CATB) FAQ

As of the most recent data (September 2025), CATB shows a common stock of $57K. Scroll down for historical charts and peer comparison views.

Tracking CATB's common stock over time shows whether Catabasis Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $57K Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Catabasis Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $57K) with ownership activity and broader fundamentals.

Catabasis Pharmaceuticals's common stock is $57K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.